Peptides in the Clinic: What Providers Need to Know Before Offering Peptide Therapy

Peptide therapy is one of the fastest-growing areas in clinical practice — and one of the most confusing when it comes to what's legal, what's evidence-based, and what actually belongs in your clinic. In this episode of The Real World Provider, Danni Owens, FNP-BC, breaks down the peptides every healthcare provider should know about in 2026: from healing peptides like BPC-157 and TB-500, to growth hormone secretagogues like ipamorelin and CJC-1295, to immune modulators, cognitive enhancers, longevity peptides, and more. This episode covers the 2026 FDA reclassification announcement, the difference between Category 1 and Category 2 peptides, what RFK Jr.'s announcement actually means for your practice, and the five things every provider needs to do before prescribing peptide therapy. If you're an NP, PA, or physician offering — or considering — peptide therapy in your clinic, this is your real-world guide. Peptides covered: BPC-157, TB-500, GHK-Cu, Ipamorelin, CJC-1295, Sermorelin, Thymosin Alpha-1, AOD-9604, Selank, Semax, KPV, MOTS-c, Epitalon, DSIP, and Kisspeptin-10.